Triptorelin
Decapeptyl, Trelstar, Gonapeptyl, Pamorelin
A synthetic GnRH agonist decapeptide that suppresses gonadotropin and sex hormone production for treating prostate cancer, endometriosis, and precocious puberty.
Active Not Recruiting
PHASE2
NCT03944434
FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
Fondazione Sandro Pitigliani
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT03954197
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
Hôpital Jean Verdier
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06481696
Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility
Andros Day Surgery Clinic
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT02979886
Effects of SNP of GnRH Receptor Genes in IVF Patients
Miao benyu
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE3
NCT01125488
Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery
Taipei Veterans General Hospital, Taiwan
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT07187947
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting
NCT06473259
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
Santa Chiara Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT04727671
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
Damascus University
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE1
NCT03332797
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
Genentech, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT02201914
Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF
Bioroma
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT04248621
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
Wonju Severance Christian Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT01634724
GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation
Nanjing University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT00633347
Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation
Instituto Valenciano de Infertilidad, IVI VALENCIA
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT02144818
GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response
Sheba Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02244151
Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval
Instituto de Investigacion Sanitaria La Fe
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE1, PHASE2
NCT04616729
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
Universitair Ziekenhuis Brussel
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT02741154
Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI
Minia University
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT04407065
Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles
Riyadh Fertility and Reproductive Health center
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT00066807
Premenopausal Endocrine Responsive Chemotherapy Trial
ETOP IBCSG Partners Foundation
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2, PHASE3
NCT01603420
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Proton Collaborative Group
INTERVENTIONAL
Updated Dec 15, 2025